Invention Grant
- Patent Title: Nanoparticulate and controlled release compositions comprising cefditoren
- Patent Title (中): 包含头孢托仑的纳米颗粒和控释组合物
-
Application No.: US11671276Application Date: 2007-02-05
-
Publication No.: US08119163B2Publication Date: 2012-02-21
- Inventor: John G Devane , Paul Stark , Niall M. N. Fanning , Gurvinder Singh Rekhi , Scott A. Jenkins , Gary Liversidge
- Applicant: John G Devane , Paul Stark , Niall M. N. Fanning , Gurvinder Singh Rekhi , Scott A. Jenkins , Gary Liversidge
- Applicant Address: IE Dublin
- Assignee: Alkermes Pharma Ireland Limited
- Current Assignee: Alkermes Pharma Ireland Limited
- Current Assignee Address: IE Dublin
- Agency: Fox Rothschild LLP
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/16 ; A61K9/50 ; A61K9/54
Abstract:
The present invention provides a composition comprising a cefditoren, or a salt, derivative, prodrug, or other form thereof, for example, cefditoren pivoxil, useful in the treatment and prevention of infections and related conditions. The invention provides a composition which comprises nanoparticulate particles comprising the cefditoren, or a salt, derivative, prodrug, or other form thereof and at least one surface stabilizer. The nanoparticulate particles have an effective average particle size of less than about 2000 nm. The invention provides also a composition that delivers a cefditoren, or a salt, derivative, prodrug, or other form thereof, or nanoparticles comprising the same, in a pulsatile or continuous manner.
Public/Granted literature
- US20080279929A1 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren Public/Granted day:2008-11-13
Information query
